首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
【24h】

Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.

机译:立体选择性合成和生物学评估(R)-内酯,(6R)-((4​​R)-羟基-6-苯基-己-2-基)-5,6-二氢吡喃-2-酮及其4S差向异构体。

获取原文
获取原文并翻译 | 示例
           

摘要

A simple and highly efficient synthetic route has been developed for synthesis of (R)-rugulactone (1a), (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one (1b) and its 4S epimer 1c by employing proline-catalyzed alpha-aminooxylation, Sharpless epoxidation, Mitsunobu reaction as chirality introuducing steps. The antibacterial and antifungal activity of the compounds 1a, 1b and 1c were evaluated. 1a and 1b showed better antibacterial activity against Pseudomonas aeroginosa (MIC=12.5 microg/ml for 1a, 25 microg/ml for 1b) Klebsiella pneumonia (MIC=25 microg/ml for 1a). Compounds (1a, 1b, 1c) exhibited good to moderate antifungal activity.
机译:已开发出一种简单而高效的合成路线,用于合成(R)-丁内酯(1a),(6R)-((4​​R)-羟基-6-苯基-己-2-烯基)-5,6-二氢-吡喃-2-酮(1b)及其4S差向异构体1c通过采用脯氨酸催化的α-氨氧基化,Sharpless环氧化,Mitsunobu反应作为手性诱导步骤。评价了化合物1a,1b和1c的抗菌和抗真菌活性。图1a和1b显示了更好的针对铜绿假单胞菌的抗菌活性(1a的MIC = 12.5微克/毫升,1b的25微克/毫升)对克雷伯氏肺炎(1a的MIC = 25微克/毫升)。化合物(1a,1b,1c)表现出良好至中等的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号